Levetiracetam Cristers

Levetiracetam, the active ingredient in Levetiracetam Cristers, is an antiepileptic presented as an oral formulation for oral use. It is prescribed to manage various seizure types in patients diagnosed with epilepsy, including partial‑onset and generalized tonic‑clonic seizures.

GNH USA supplies Levetiracetam Cristers as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU GMP standards and providing batch‑tested, quality‑assured medication for global distribution, and is available for import by qualified healthcare institutions.

Levetiracetam is used within the antiepileptic drug class to control seizure activity across several epilepsy syndromes.

- Epilepsy: reduces overall seizure frequency in patients with diagnosed epilepsy. - Partial‑onset seizures: controls focal seizures that originate in one brain region. - Generalized tonic‑clonic seizures: prevents convulsive episodes that involve the whole brain.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or low in energy. - Headache: mild to moderate cranial pain. - Irritability: increased mood lability or agitation.

Serious or Rare Side Effects: - Severe allergic reaction: signs of anaphylaxis such as swelling or difficulty breathing. - Stevens‑Johnson syndrome: rare skin blistering and mucosal involvement. - Suicidal thoughts or behavior: emergence of depressive symptoms or self‑harm ideation.

When prescribing levetiracetam, clinicians should consider several safety aspects.

- Renal function: adjust dosing in patients with impaired clearance. - Pregnancy: Category B, but discuss potential risks with the patient. - Concomitant CNS depressants: monitor for enhanced sedation. - Psychiatric history: observe for mood changes or depression. - Driving: advise caution due to possible dizziness. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels. - Phenobarbital: can decrease levetiracetam exposure. - Phenytoin: may reduce levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: additive central nervous system depression. - Benzodiazepines: increased sedative effect. - Fluoroquinolones: potential for heightened neurotoxicity.